The Simplified Psoriasis Index (SPI): a practical tool for assessing psoriasis

Area of Science:

• Dermatology
• Clinical Assessment Tools
• Psoriasis Research

Background:

• The Psoriasis Area and Severity Index (PASI) is a standard measure, but the Simplified Psoriasis Index (SPI) was developed to provide a composite score reflecting functional and psychosocial impact.
• The SPI includes components for current severity (SPI-s), psychosocial impact (SPI-p), and past history/interventions (SPI-i).
• Two versions of SPI-s exist: professionally assessed (proSPI-s) and patient self-assessed (saSPI-s).

Purpose of the Study:

• To evaluate the criterion and construct validity of proSPI-s, saSPI-s, and SPI-p in patients with plaque psoriasis.
• To assess the response distribution of these SPI components.
• To determine the test-retest reliability of proSPI-s, saSPI-s, and SPI-p, and the interrater reliability of proSPI-s.

Main Methods:

• Criterion and construct validity were examined in 100 plaque psoriasis patients.
• Test-retest reliability was assessed in 50 patients for proSPI-s, saSPI-s, and SPI-p.
• Interrater reliability of proSPI-s was evaluated using 12 patients and 12 assessors (144 assessments).

Main Results:

• A high correlation was found between the Psoriasis Area and Severity Index (PASI) and proSPI-s (r=0.91).
• SPI-p showed a strong correlation with the Dermatology Life Quality Index (DLI) (r=0.89).
• All SPI components demonstrated strong intrarater reliability, and proSPI-s showed strong interrater reliability (intraclass correlation coefficients >0.75), with wide response distributions.

Conclusions:

• The Simplified Psoriasis Index (SPI), including both professional (proSPI) and self-assessed (saSPI) versions, exhibits strong validity and reliability.
• These findings support the potential for readily integrating proSPI and saSPI into routine clinical practice for psoriasis management.
• The SPI provides a comprehensive measure of psoriasis severity and its impact on patients' lives.